newsfilter
← Latest News
GlobeNewswire·

XTL Biopharmaceuticals Confirms that it has not Experienced any Disruption to its Business Operations in Israel

Ramat Gan, Israel, Oct. 20, 2023 (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (NASDAQ:XTLB, TASE: XTLB.TA)) ("XTL" or the "Company"), a clinical stage biopharmaceutical company whose main assets